Multiple Sclerosis treatment breakthrough
(Pixabay) Thanks to COVID and virus research, a new mRNA ‘Vaccine Treatment’ for MS is in final development. The Multiple Sclerosis Society of Canada made the announcement in their January 25, 2021 Newsletter. They wrote: “BioNTech is Applying mRNA Vaccine Technology to Treat Multiple Sclerosis. BioNTech, a German biotechnology company that is working with Pfizer to develop a COVID-19 vaccine, reports that they are using the same technology to develop a therapeutic approach to multiple sclerosis (MS).” Jan. 25, 2021 Yahoo Finance Reports on BioNTech; “With the MS vaccine, the mRNA t...
Source: moosejawtoday.com